Table of Contents

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research Assumptions

2. Executive Summary

2.1 Market Overview

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.1 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

4.3 Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting

5.1 Prescription Trends of SGLT2 Inhibitors (2023), by Region

5.2 Production and Usage Volume of SGLT2 Inhibitor Drugs (2020–2023)

5.3 Healthcare Spending on SGLT2 Inhibitors (2023)

5.4 Regulatory Approvals and Clinical Trial Trends (2020–2023)

6. Competitive Landscape

6.1 List of Major Companies, By Region

6.2 Market Share Analysis, By Region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and promotional activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion plans and new Product launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. SGLT2 Inhibitors Market Segmentation By Indication

7.1 Chapter Overview

      7.2 Chronic Kidney Disease (CKD)

7.2.1 Chronic Kidney Disease (CKD) Market Trends Analysis (2021-2032)

7.2.2 Chronic Kidney Disease (CKD) Market Size Estimates and Forecasts to 2032 (USD Billion)

7.3 Type 2 Diabetes

     7.3.1 Type 2 Diabetes Market Trends Analysis (2021-2032)

          7.3.2 Type 2 Diabetes Market Size Estimates and Forecasts to 2032 (USD Billion)

7.4 Cardiovascular

     7.4.1 Cardiovascular Market Trends Analysis (2021-2032)

          7.4.2 Cardiovascular Market Size Estimates and Forecasts to 2032 (USD Billion)

7.5 Others

     7.5.1 Others Market Trends Analysis (2021-2032)

          7.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)

8. SGLT2 Inhibitors Market Segmentation By Drug

8.1 Chapter Overview

     8.2 Jardiance (Empagliflozin)

            8.2.1 Jardiance (Empagliflozin) Market Trend Analysis (2021-2032)

           8.2.2 Jardiance (Empagliflozin) Market Size Estimates and Forecasts to 2032 (USD Billion)

8.3 Inpefa (Sotagliflozin)

      8.3.1 Inpefa (Sotagliflozin) Market Trends Analysis (2021-2032)

           8.3.2 Inpefa (Sotagliflozin) Market Size Estimates and Forecasts to 2032 (USD Billion)

8.4 Farxiga (Dapagliflozin)

      8.4.1 Farxiga (Dapagliflozin) Market Trends Analysis (2021-2032)

           8.4.2 Farxiga (Dapagliflozin) Market Size Estimates and Forecasts to 2032 (USD Billion)

8.5 Invokana (Canagliflozin)

      8.5.1 Invokana (Canagliflozin) Market Trends Analysis (2021-2032)

           8.5.2 Invokana (Canagliflozin) Market Size Estimates and Forecasts to 2032 (USD Billion)

8.6 Qtern (Dapagliflozin/Saxagliptin)

      8.6.1 Qtern (Dapagliflozin/Saxagliptin) Market Trends Analysis (2021-2032)

           8.6.2 Qtern (Dapagliflozin/Saxagliptin) Market Size Estimates and Forecasts to 2032 (USD Billion)

8.7 Others

      8.7.1 Others Market Trends Analysis (2021-2032)

           8.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)

9. SGLT2 Inhibitors Market Segmentation By Distribution Channel

9.1 Chapter Overview

9.2 Hospital Pharmacies

        9.2.1 Hospital Pharmacies Market Trends Analysis (2021-2032)

9.2.2 Hospital Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)

9.3 Retail Pharmacies

        9.3.1 Retail Pharmacies Market Trends Analysis (2021-2032)

9.3.2 Retail Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)

9.4 Online Pharmacies

        9.4.1 Online Pharmacies Market Trends Analysis (2021-2032)

9.4.2 Online Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)

10. Regional Analysis

10.1 Chapter Overview

10.2 North America

10.2.1 Trends Analysis

10.2.2 North America SGLT2 Inhibitors Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

10.2.3 North America SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion) 

10.2.4 North America SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.2.5 North America SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.2.6 USA

10.2.6.1 USA SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.2.6.2 USA SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.2.6.3 USA SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.2.7 Canada

10.2.7.1 Canada SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.2.7.2 Canada SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.2.7.3 Canada SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.2.8 Mexico

10.2.8.1 Mexico SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.2.8.2 Mexico SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.2.8.3 Mexico SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3 Europe

10.3.1 Trends Analysis

10.3.2 Europe SGLT2 Inhibitors Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

10.3.3 Europe SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion) 

10.3.4 Europe SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.5 Europe SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3.6 Germany

10.3.6.1 Germany SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.3.6.2 Germany SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.6.3 Germany SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3.7 France

10.3.7.1 France SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.3.7.2 France SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.7.3 France SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3.8 UK

10.3.8.1 UK SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.3.8.2 UK SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.8.3 UK SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3.9 Italy

10.3.9.1 Italy SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.3.9.2 Italy SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.9.3 Italy SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3.10 Spain

10.3.10.1 Spain SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.3.10.2 Spain SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.10.3 Spain SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3.11 Poland

10.3.11.1 Poland SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.3.11.2 Poland SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.11.3 Poland SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3.12 Turkey

10.3.12.1 Turkey SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.3.12.2 Turkey SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.12.3 Turkey SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.3.13 Rest of Europe

10.3.13.1 Rest of Europe SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.3.13.2 Rest of Europe SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.3.13.3 Rest of Europe SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.4 Asia Pacific

10.4.1 Trends Analysis

10.4.2 Asia Pacific SGLT2 Inhibitors Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

10.4.3 Asia Pacific SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion) 

10.4.4 Asia Pacific SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.4.5 Asia Pacific SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.4.6 China

10.4.6.1 China SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.4.6.2 China SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.4.6.3 China SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.4.7 India

10.4.7.1 India SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.4.7.2 India SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.4.7.3 India SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.4.8 Japan

10.4.8.1 Japan SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.4.8.2 Japan SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.4.8.3 Japan SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.4.9 South Korea

10.4.9.1 South Korea SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.4.9.2 South Korea SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.4.9.3 South Korea SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.4.10 Singapore

10.4.10.1 Singapore SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.4.10.2 Singapore SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.4.10.3 Singapore SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.4.11 Australia

10.4.11.1 Australia SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.4.11.2 Australia SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.4.11.3 Australia SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.4.12 Rest of Asia Pacific

10.4.12.1 Rest of Asia Pacific SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.4.12.2 Rest of Asia Pacific SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.4.12.3 Rest of Asia Pacific SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.5 Middle East and Africa

10.5.1 Trends Analysis

10.5.2 Middle East and Africa SGLT2 Inhibitors Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

10.5.3 Middle East and Africa SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion) 

10.5.4 Middle East and Africa SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.5.5 Middle East and Africa SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.5.6 UAE

10.5.6.1 UAE SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.5.6.2 UAE SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.5.6.3 UAE SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.5.7 Saudi Arabia

10.5.7.1 Saudi Arabia SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.5.7.2 Saudi Arabia SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.5.7.3 Saudi Arabia SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.5.8 Qatar

10.5.8.1 Qatar SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.5.8.2 Qatar SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.5.8.3 Qatar SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.5.9 South Africa

10.5.9.1 South Africa SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.5.9.2 South Africa SGLT2 Inhibitors Market Estimates and Forecasts By Drug (2021-2032) (USD Billion)

10.5.9.3 South Africa SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.5.10 Rest of Middle East & Africa

10.5.10.1 Rest of Middle East & Africa SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.5.10.2 Rest of Middle East & Africa SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.5.10.3 Rest of Middle East & Africa SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.6 Latin America

10.6.1 Trends Analysis

10.6.2 Latin America SGLT2 Inhibitors Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

10.6.3 Latin America SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion) 

10.6.4 Latin America SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.6.5 Latin America SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.6.6 Brazil

10.6.6.1 Brazil SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.6.6.2 Brazil SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.6.6.3 Brazil SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.6.7 Argentina

10.6.7.1 Argentina SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.6.7.2 Argentina SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.6.7.3 Argentina SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10.6.8 Rest of Latin America

10.6.8.1 Rest of Latin America SGLT2 Inhibitors Market Estimates and Forecasts, By Indication (2021-2032) (USD Billion)

10.6.8.2 Rest of Latin America SGLT2 Inhibitors Market Estimates and Forecasts, By Drug (2021-2032) (USD Billion)

10.6.8.3 Rest of Latin America SGLT2 Inhibitors Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

11. Company Profiles

11.1 Boehringer Ingelheim International GmbH

11.1.1 Company Overview

11.1.2 Financial

11.1.3 Product/ Services Offered

11.1.4 SWOT Analysis

11.2 Sanofi

11.2.1 Company Overview

11.2.2 Financial

11.2.3 Product/ Services Offered

11.2.4 SWOT Analysis

11.3 AstraZeneca

11.3.1 Company Overview

11.3.2 Financial

11.3.3 Product/ Services Offered

11.3.4 SWOT Analysis

11.4 TheracosBio, LLC

11.4.1 Company Overview

11.4.2 Financial

11.4.3 Product/ Services Offered

11.4.4 SWOT Analysis

11.5 Merck & Co., Inc.

11.5.1 Company Overview

11.5.2 Financial

11.5.3 Product/ Services Offered

11.5.4 SWOT Analysis

11.6 TheracosBio, LLC

11.6.1 Company Overview

11.6.2 Financial

11.6.3 Product/ Services Offered

11.6.4 SWOT Analysis

11.7 Glenmark Pharmaceuticals Ltd.

11.7.1 Company Overview

11.7.2 Financial

11.7.3 Product/ Services Offered

11.7.4 SWOT Analysis

11.8 Lexicon Pharmaceuticals, Inc.

11.8.1 Company Overview

11.8.2 Financial

11.8.3 Product/ Services Offered

11.8.4 SWOT Analysis

11.9 Eli Lilly and Company

11.9.1 Company Overview

11.9.2 Financial

11.9.3 Product/ Services Offered

11.9.4 SWOT Analysis

11.10 Johnson & Johnson Services, Inc.

11.10.1 Company Overview

11.10.2 Financial

11.10.3 Product/ Services Offered

11.10.4 SWOT Analysis

12. Use Cases and Best Practices

13. Conclusion